There were 1,777 press releases posted in the last 24 hours and 403,505 in the last 365 days.

Allegro MicroSystems Reports Third Quarter 2025 Results

MANCHESTER, N.H., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its third quarter ended December 27, 2024.  

“We delivered on our commitments with third quarter sales of $178 million and non-GAAP EPS of $0.07, both above the midpoint of our guidance,” said Vineet Nargolwala, President and CEO of Allegro. “During the quarter, we introduced a record number of new magnetic sensing and power products to the market, further expanding our differentiated portfolios. This increasing velocity further solidifies our market leadership and positions us well for above market growth.”

Third Quarter Financial Highlights:

In thousands, except per share data   Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Net Sales                              
Automotive   $ 130,066     $ 141,893     $ 194,764     $ 403,143     $ 577,515  
Industrial and other     47,806       45,498       60,220       129,039       231,271  
Total net sales   $ 177,872     $ 187,391     $ 254,984     $ 532,182     $ 808,786  
GAAP Financial Measures                              
Gross margin %     45.7 %     45.7 %     52.5 %     45.4 %     55.8 %
Operating margin %     %     2.2 %     14.4 %     (1.2 )%     22.3 %
Diluted EPS   $ (0.04 )   $ (0.18 )   $ 0.17     $ (0.31 )   $ 0.82  
Non-GAAP Financial Measures                              
Gross margin %     49.1 %     48.8 %     54.6 %     48.9 %     57.0 %
Operating margin %     10.8 %     11.7 %     27.2 %     9.6 %     29.8 %
Diluted EPS   $ 0.07     $ 0.08     $ 0.32     $ 0.18     $ 1.11  
                                         

Business Outlook

For the fourth quarter of fiscal year 2025 ending March 28, 2025, the Company expects total net sales to be in the range of $180 million to $190 million.

The Company also estimates the following results on a non-GAAP basis:

  • Gross Margin is expected to be between 46% and 48%, which contemplates the impact of annual pricing agreements ahead of cost reductions, as well as higher capacity charges resulting from adjusted production levels in the quarter,
  • Operating expenses are expected to increase by approximately 5% sequentially to $72 million, primarily  due to annual payroll tax resets,
  • As a result of the expected repricing of the term loan and anticipated $30 million Q4 debt repayment, the Company now expects Interest Expense to be approximately $6 million, and
  • Diluted Earnings per Share are expected to be between $0.03 and $0.07.

Allegro has not provided a reconciliation of its fourth fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Interest Expense, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.

Earnings Webcast

A webcast will be held on Thursday, January 30, 2025 at 8:30 a.m., Eastern Time. Vineet Nargolwala, President and Chief Executive Officer, and Derek P. D’Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits (“ICs”) and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro’s diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power saving technologies for data centers and clean energy applications.

Forward-Looking Statements         

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 29, 2024, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix, customer mix or channel mix, which could negatively impact our gross margin; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control impacting us, our key suppliers or our manufacturing partners; our ability to develop new product features or new products in a timely and cost-effective manner; our ability to manage growth; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers’ quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to effectively manage our growth and to retain key and highly skilled personnel; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or confidential information or those of our third-party service providers; our principal stockholder continues to have influence over us; anti-takeover provisions in our organizational documents and under the General Corporation Law of the State of Delaware; any failure to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; the physical, transition and litigation risks presented by climate change; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their most directly comparable GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.



ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(Unaudited)
 
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
Net sales   $ 177,872     $ 254,984     $ 532,182     $ 808,786  
Cost of goods sold     96,657       121,156       290,534       357,505  
Gross profit     81,215       133,828       241,648       451,281  
Operating expenses:                        
Research and development     43,317       44,396       132,031       130,799  
Selling, general and administrative     37,939       52,746       116,221       140,135  
Total operating expenses     81,256       97,142       248,252       270,934  
Operating (loss) income     (41 )     36,686       (6,604 )     180,347  
Interest and other (expense) income     (7,561 )     (315 )     (25,902 )     (2,801 )
Loss on change in fair value of forward repurchase contract                 (34,752 )      
(Loss) income before income taxes     (7,602 )     36,371       (67,258 )     177,546  
Income tax (benefit) provision     (803 )     2,969       (9,233 )     17,584  
Net (loss) income     (6,799 )     33,402       (58,025 )     159,962  
Net income attributable to non-controlling interests     61       57       185       150  
Net (loss) income attributable to Allegro MicroSystems, Inc.   $ (6,860 )   $ 33,345     $ (58,210 )   $ 159,812  
Net (loss) income per common share attributable to Allegro MicroSystems, Inc.:                        
Basic   $ (0.04 )   $ 0.17     $ (0.31 )   $ 0.83  
Diluted   $ (0.04 )   $ 0.17     $ (0.31 )   $ 0.82  
Weighted average shares outstanding:                        
Basic     184,011,189       192,724,541       188,886,583       192,384,315  
Diluted     184,011,189       194,570,380       188,886,583       194,925,040  
 

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited condensed consolidated statements of operations:

    Three-Month Period Ended     Change     Nine-Month Period Ended     Change  
    December 27, 2024     December 29, 2023     Amount     %     December 27, 2024     December 29, 2023     Amount     %  
    (Dollars in thousands)     (Dollars in thousands)  
Automotive   $ 130,066     $ 194,764     $ (64,698 )     (33 )%   $ 403,143     $ 577,515     $ (174,372 )     (30 )%
Industrial and other     47,806       60,220       (12,414 )     (21 )%     129,039       231,271       (102,232 )     (44 )%
Total net sales   $ 177,872     $ 254,984     $ (77,112 )     (30 )%   $ 532,182     $ 808,786     $ (276,604 )     (34 )%
 


ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
    December 27,     March 29,  
    2024
(Unaudited)
    2024

 
Assets            
Current assets:            
Cash and cash equivalents   $ 138,452     $ 212,143  
Restricted cash     10,510       10,018  
Trade accounts receivable, net     83,805       118,508  
Inventories     193,140       162,302  
Prepaid income taxes     36,037       31,908  
Prepaid expenses and other current assets     33,683       33,584  
Current portion of related party notes receivable           3,750  
Total current assets     495,627       572,213  
Property, plant and equipment, net     320,975       321,175  
Deferred income tax assets     65,398       54,496  
Goodwill     202,101       202,425  
Intangible assets, net     261,553       276,854  
Related party notes receivable, less current portion           4,688  
Equity investment in related party     30,914       26,727  
Other assets     65,172       72,025  
Total assets   $ 1,441,740     $ 1,530,603  
Liabilities, Non-Controlling Interests and Stockholders’ Equity            
Current liabilities:            
Trade accounts payable   $ 39,685     $ 35,964  
Amounts due to related party     2,102       1,626  
Accrued expenses and other current liabilities     57,751       76,389  
Current portion of long-term debt     1,374       3,929  
Total current liabilities     100,912       117,908  
Long-term debt     374,729       249,611  
Other long-term liabilities     31,673       31,368  
Total liabilities     507,314       398,887  
Commitments and contingencies            
Stockholders’ Equity:            
Preferred stock            
Common stock     1,840       1,932  
Additional paid-in capital     1,004,080       694,332  
(Accumulated deficit) retained earnings     (38,791 )     463,012  
Accumulated other comprehensive loss     (34,084 )     (28,841 )
Equity attributable to Allegro MicroSystems, Inc.     933,045       1,130,435  
Non-controlling interests     1,381       1,281  
Total stockholders’ equity     934,426       1,131,716  
Total liabilities, non-controlling interests and stockholders’ equity   $ 1,441,740     $ 1,530,603  


ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
 
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
Cash flows from operating activities:                        
Net (loss) income   $ (6,799 )   $ 33,402     $ (58,025 )   $ 159,962  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:                        
Depreciation and amortization     16,123       20,195       48,578       49,548  
Amortization of deferred financing costs     694       185       1,781       292  
Deferred income taxes     (3,751 )     (10,119 )     (11,546 )     (28,253 )
Stock-based compensation     10,588       10,920       32,251       32,839  
Loss on change in fair value of forward repurchase contract                 34,752        
Provisions for inventory and expected credit losses     3,031       429       7,519       9,851  
Change in fair value of marketable securities                       3,579  
Other non-cash reconciling items     68       (25 )     6,645       18  
Changes in operating assets and liabilities:                        
Trade accounts receivable     (7,061 )     5,081       34,356       (2,564 )
Inventories     (19,243 )     11,312       (38,074 )     (19,909 )
Prepaid expenses and other assets     14,407       7,368       (1,401 )     (13,085 )
Trade accounts payable     (8,203 )     (12,299 )     5,467       (9,604 )
Due to and from related parties     (3,568 )     705       564       6,817  
Accrued expenses and other current and long-term liabilities     (4,469 )     9,404       (21,307 )     (20,540 )
Net cash (used in) provided by operating activities     (8,183 )     76,558       41,560       168,951  
Cash flows from investing activities:                        
Purchases of property, plant and equipment     (13,615 )     (34,399 )     (34,564 )     (110,500 )
Acquisition of business, net of cash acquired     319       (408,119 )     319       (408,119 )
Sales of marketable securities                       16,175  
Net cash used in investing activities     (13,296 )     (442,518 )     (34,245 )     (502,444 )
Cash flows from financing activities:                        
Net proceeds from Refinanced 2023 Term Loan Facility                 193,483        
Repayment of 2023 Term Loan Facility     (25,000 )           (75,000 )      
Borrowings of senior secured debt, net of deferred financing costs           245,452             245,452  
Repayment of 2020 Term Loan Facility           (25,000 )           (25,000 )
Repayments of other debt           (743 )           (743 )
Finance lease payments     (318 )           (703 )      
Receipts on related party notes receivable           938       1,875       2,813  
Payments for taxes related to net share settlement of equity awards     (483 )     (10,732 )     (12,780 )     (24,823 )
Proceeds from issuance of common stock under employee stock purchase plan                 1,987       1,899  
Repurchases of common stock     (116 )           (853,921 )      
Net proceeds from issuance of common stock                 665,850        
Payment of debt issuance costs                       (1,450 )
Net cash (used in) provided by financing activities     (25,917 )     209,915       (79,209 )     198,148  
Effect of exchange rate changes on cash and cash equivalents and restricted cash     (2,680 )     1,349       (1,305 )     375  
Net (decrease) increase in cash and cash equivalents and restricted cash     (50,076 )     (154,696 )     (73,199 )     (134,970 )
Cash and cash equivalents and restricted cash at beginning of period     199,038       378,431       222,161       358,705  
Cash and cash equivalents and restricted cash at end of period:   $ 148,962     $ 223,735     $ 148,962     $ 223,735  
 

Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision, non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as percentage of net sales (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related-party activities and other non-operational costs.

Non-GAAP Income Tax Provision

In calculating non-GAAP Income Tax Provision, we have added back the following to GAAP Income Tax Provision:

  • Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below and elimination of discrete tax adjustments.
Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin  
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Gross Profit   $ 81,215     $ 85,662     $ 133,828     $ 241,648     $ 451,281  
GAAP Gross Margin (% of net sales)     45.7 %     45.7 %     52.5 %     45.4 %     55.8 %
                               
Non-GAAP adjustments                              
Transaction-related costs     5       10       523       14       523  
Purchased intangible amortization     4,875       4,875       3,648       14,625       4,323  
Restructuring costs     522       16       166       1,738       166  
Stock-based compensation     802       817       1,073       2,180       4,625  
Total Non-GAAP Adjustments   $ 6,204     $ 5,718     $ 5,410     $ 18,557     $ 9,637  
                               
Non-GAAP Gross Profit   $ 87,419     $ 91,380     $ 139,238     $ 260,205     $ 460,918  
Non-GAAP Gross Margin (% of net sales)     49.1 %     48.8 %     54.6 %     48.9 %     57.0 %


Reconciliation of Non-GAAP Operating Expenses  
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Operating Expenses   $ 81,256     $ 81,595     $ 97,142     $ 248,252     $ 270,934  
                               
Research and Development Expenses                              
GAAP Research and Development Expenses     43,317       43,510       44,396       132,031       130,799  
Non-GAAP adjustments                              
Transaction-related costs     333       206       343       1,568       352  
Restructuring costs     568       260       908       997       908  
Stock-based compensation     3,960       3,523       3,870       11,218       10,340  
Other costs(1)           3             3        
Non-GAAP Research and Development Expenses     38,456       39,518       39,275       118,245       119,199  
                               
Selling, General and Administrative Expenses                              
GAAP Selling, General and Administrative Expenses     37,939       38,085       52,746       116,221       140,135  
Non-GAAP adjustments                              
Transaction-related costs     148       275       9,543       1,237       14,419  
Purchased intangible amortization     535       535       495       1,605       1,210  
Restructuring costs     1,264       2,046       5,795       4,355       5,795  
Stock-based compensation     5,826       7,205       5,977       18,853       17,874  
Other costs(1)     391       (1,820 )     283       (618 )     383  
Non-GAAP Selling, General and Administrative Expenses     29,775       29,844       30,653       90,789       100,454  
                               
Total Non-GAAP Adjustments     13,025       12,233       27,214       39,218       51,281  
                               
Non-GAAP Operating Expenses   $ 68,231     $ 69,362     $ 69,928     $ 209,034     $ 219,653  
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.  


Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin  
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Operating (Loss) Income   $ (41 )   $ 4,067     $ 36,686     $ (6,604 )   $ 180,347  
GAAP Operating Margin (% of net sales)     %     2.2 %     14.4 %     (1.2 )%     22.3 %
                               
Transaction-related costs     486       491       10,409       2,819       15,294  
Purchased intangible amortization     5,410       5,410       4,143       16,230       5,533  
Restructuring costs     2,354       2,322       6,869       7,090       6,869  
Stock-based compensation     10,588       11,545       10,920       32,251       32,839  
Other costs(1)     391       (1,817 )     283       (615 )     383  
Total Non-GAAP Adjustments   $ 19,229     $ 17,951     $ 32,624     $ 57,775     $ 60,918  
                               
Non-GAAP Operating Income   $ 19,188     $ 22,018     $ 69,310     $ 51,171     $ 241,265  
Non-GAAP Operating Margin (% of net sales)     10.8 %     11.7 %     27.2 %     9.6 %     29.8 %
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.  


Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin  
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Net (Loss) Income   $ (6,799 )   $ (33,613 )   $ 33,402     $ (58,025 )   $ 159,962  
GAAP Net (Loss) Income Margin (% of net sales)     (3.8 )%     (17.9 )%     13.1 %     (10.9 )%     19.8 %
                               
Interest expense     7,762       10,353       3,854       23,492       5,381  
Interest income     (388 )     (420 )     (857 )     (1,302 )     (2,550 )
Income tax (benefit) provision     (803 )     (9,470 )     2,969       (9,233 )     17,584  
Depreciation & amortization     16,123       15,997       20,227       48,578       49,645  
EBITDA   $ 15,895     $ (17,153 )   $ 59,595     $ 3,510     $ 230,022  
                               
Transaction-related costs     486       3,295       10,409       5,623       15,294  
Restructuring costs     2,354       2,067       6,869       6,835       6,869  
Stock-based compensation     10,588       11,545       10,920       32,251       32,839  
Loss on change in fair value of forward repurchase contract           34,752             34,752        
Other costs(1)     998       (2,195 )     (551 )     1,610       5,339  
Adjusted EBITDA   $ 30,321     $ 32,311     $ 87,242     $ 84,581     $ 290,363  
Adjusted EBITDA Margin (% of net sales)     17.0 %     17.2 %     34.2 %     15.9 %     35.9 %
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, and income (loss) in earnings of equity investments.  


Reconciliation of Non-GAAP Profit before Tax  
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP (Loss) Income before Income Taxes   $ (7,602 )   $ (43,083 )   $ 36,371     $ (67,258 )   $ 177,546  
                               
Transaction-related costs     486       3,295       10,409       5,623       15,294  
Transaction-related interest     192       141       162       1,042       162  
Purchased intangible amortization     5,410       5,410       4,143       16,230       5,533  
Restructuring costs     2,354       2,067       6,869       6,835       6,869  
Stock-based compensation     10,588       11,545       10,920       32,251       32,839  
Loss on change in fair value of forward repurchase contract           34,752             34,752        
Other costs(1)     1,427       1,428       (551 )     5,662       5,339  
Total Non-GAAP Adjustments   $ 20,457     $ 58,638     $ 31,952     $ 102,395     $ 66,036  
                               
Non-GAAP Profit before Tax   $ 12,855     $ 15,555     $ 68,323     $ 35,137     $ 243,582  
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, and income (loss) in earnings of equity investments.  


Reconciliation of Non-GAAP Income Tax Provision and Non-GAAP Effective Tax Rate  
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Income Tax (Benefit) Provision   $ (803 )   $ (9,470 )   $ 2,969     $ (9,233 )   $ 17,584  
GAAP effective tax rate     10.6 %     22.0 %     8.2 %     13.7 %     9.9 %
                               
Tax effect of adjustments to GAAP results     398       10,071       3,748       10,074       10,128  
                               
Non-GAAP Income Tax (Benefit) Provision   $ (405 )   $ 601     $ 6,717     $ 841     $ 27,712  
Non-GAAP effective tax rate     (3.2 )%     3.9 %     9.8 %     2.4 %     11.4 %


Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share  
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc.(1)   $ (6,860 )   $ (33,675 )   $ 33,345     $ (58,210 )   $ 159,812  
GAAP Basic weighted average common shares     184,011,189       189,182,850       192,724,541       188,886,583       192,384,315  
GAAP Diluted weighted average common shares     184,011,189       189,182,850       194,570,380       188,886,583       194,925,040  
GAAP Basic (Loss) Earnings per Share   $ (0.04 )   $ (0.18 )   $ 0.17     $ (0.31 )   $ 0.83  
GAAP Diluted (Loss) Earnings per Share   $ (0.04 )   $ (0.18 )   $ 0.17     $ (0.31 )   $ 0.82  
                               
Transaction-related costs     486       3,295       10,409       5,623       15,294  
Transaction-related interest     192       141       162       1,042       162  
Purchased intangible amortization     5,410       5,410       4,143       16,230       5,533  
Restructuring costs     2,354       2,067       6,869       6,835       6,869  
Stock-based compensation     10,588       11,545       10,920       32,251       32,839  
Loss on change in fair value of forward repurchase contract           34,752             34,752        
Other costs(2)     1,427       1,428       (551 )     5,662       5,339  
Total Non-GAAP Adjustments     20,457       58,638       31,952       102,395       66,036  
Tax effect of adjustments to GAAP results(3)     (398 )     (10,071 )     (3,748 )     (10,074 )     (10,128 )
Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc.   $ 13,199     $ 14,892     $ 61,549     $ 34,111     $ 215,720  
Basic weighted average common shares     184,011,189       189,182,850       192,724,541       188,886,583       192,384,315  
Diluted weighted average common shares     184,485,792       189,710,595       194,570,380       189,577,693       194,925,040  
Non-GAAP Basic Earnings per Share   $ 0.07     $ 0.08     $ 0.32     $ 0.18     $ 1.12  
Non-GAAP Diluted Earnings per Share   $ 0.07     $ 0.08     $ 0.32     $ 0.18     $ 1.11  
                               
(1) GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc. represents GAAP Net (Loss) Income adjusted for Net Income Attributable to non-controlling interests.  
(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.  
(3) To calculate the tax effect of adjustments to GAAP results, the Company considers each non-GAAP adjustment by tax jurisdiction and reverses all discrete items to calculate an annual non-GAAP effective tax rate (“NG ETR”).  This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.  


Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales        
                               
    Three-Month Period Ended     Nine-Month Period Ended  
    December 27, 2024     September 27, 2024     December 29, 2023     December 27, 2024     December 29, 2023  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Operating Cash Flow   $ (8,183 )   $ 15,547     $ 76,558     $ 41,560     $ 168,951  
GAAP Operating Cash Flow (% of net sales)     -4.6 %     8.3 %     30.0 %     7.8 %     20.9 %
Non-GAAP adjustments                              
Purchases of property, plant and equipment     (13,615 )     (9,972 )     (34,399 )     (34,564 )     (110,500 )
                               
Non-GAAP Free Cash Flow   $ (21,798 )   $ 5,575     $ 42,159     $ 6,996     $ 58,451  
Non-GAAP Free Cash Flow (% of net sales)     (12.3 )%     3.0 %     16.5 %     1.3 %     7.2 %


Investor Contact:
Jalene Hoover
VP of Investor Relations & Corporate Communications
+1 (512) 751-6526
jhoover@allegromicro.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.